Sell

RARE Quote, Financials, Valuation and Earnings

Last price:

$38.90

Seasonality move :

14.41%

Day range:

$36.71 - $38.77

52-week range:

$36.71 - $60.37

Dividend yield:

0%

P/E ratio:

--

P/S ratio:

6.14x

P/B ratio:

13.76x

Volume:

976.7K

Avg. volume:

768K

1-year change:

-16.45%

Market cap:

$3.5B

Revenue:

$560.2M

EPS (TTM):

-$6.34

Ultragenyx Pharmaceutical SEC Filings

Company	Filed	Form Type	Description
RARE Ultragenyx Pharmaceutical	05/03/2024	10-Q	10-Q filing on 05/03/2024	View Form
RARE Ultragenyx Pharmaceutical	11/03/2023	10-Q	10-Q filing on 11/03/2023	View Form
RARE Ultragenyx Pharmaceutical	08/04/2023	10-Q	10-Q filing on 08/04/2023	View Form
RARE Ultragenyx Pharmaceutical	05/05/2023	10-Q	10-Q filing on 05/05/2023	View Form
RARE Ultragenyx Pharmaceutical	11/03/2022	10-Q	10-Q filing on 11/03/2022	View Form
RARE Ultragenyx Pharmaceutical	07/29/2022	10-Q	10-Q filing on 07/29/2022	View Form
RARE Ultragenyx Pharmaceutical	05/06/2022	10-Q	10-Q filing on 05/06/2022	View Form
RARE Ultragenyx Pharmaceutical	11/03/2021	10-Q	10-Q filing on 11/03/2021	View Form
RARE Ultragenyx Pharmaceutical	08/03/2021	10-Q	10-Q filing on 08/03/2021	View Form
RARE Ultragenyx Pharmaceutical	05/05/2021	10-Q	10-Q filing on 05/05/2021	View Form
RARE Ultragenyx Pharmaceutical	10/27/2020	10-Q	10-Q filing on 10/27/2020	View Form
RARE Ultragenyx Pharmaceutical	07/31/2020	10-Q	10-Q filing on 07/31/2020	View Form
RARE Ultragenyx Pharmaceutical	07/30/2020	10-Q	10-Q filing on 07/30/2020	View Form
RARE Ultragenyx Pharmaceutical	05/07/2020	10-Q	10-Q filing on 05/07/2020	View Form
RARE Ultragenyx Pharmaceutical	02/14/2020	10-K	10-K filing on 02/14/2020	View Form
RARE Ultragenyx Pharmaceutical	11/06/2019	10-Q	10-Q filing on 11/06/2019	View Form
RARE Ultragenyx Pharmaceutical	08/02/2019	10-Q	10-Q filing on 08/02/2019	View Form
RARE Ultragenyx Pharmaceutical	05/07/2019	10-Q	10-Q filing on 05/07/2019	View Form
RARE Ultragenyx Pharmaceutical	02/20/2019	10-K	10-K filing on 02/20/2019	View Form
RARE Ultragenyx Pharmaceutical	11/06/2018	10-Q	10-Q filing on 11/06/2018	View Form
RARE Ultragenyx Pharmaceutical	08/03/2018	10-Q	10-Q filing on 08/03/2018	View Form
RARE Ultragenyx Pharmaceutical	05/08/2018	10-Q	10-Q filing on 05/08/2018	View Form
RARE Ultragenyx Pharmaceutical	02/21/2018	10-K	10-K filing on 02/21/2018	View Form
RARE Ultragenyx Pharmaceutical	11/03/2017	10-Q	10-Q filing on 11/03/2017	View Form
RARE Ultragenyx Pharmaceutical	07/28/2017	10-Q	10-Q filing on 07/28/2017	View Form
RARE Ultragenyx Pharmaceutical	05/05/2017	10-Q	10-Q filing on 05/05/2017	View Form
RARE Ultragenyx Pharmaceutical	02/17/2017	10-K	10-K filing on 02/17/2017	View Form
RARE Ultragenyx Pharmaceutical	12/12/2016	10-Q	10-Q filing on 12/12/2016	View Form
RARE Ultragenyx Pharmaceutical	11/08/2016	10-Q	10-Q filing on 11/08/2016	View Form
RARE Ultragenyx Pharmaceutical	08/09/2016	10-Q	10-Q filing on 08/09/2016	View Form
RARE Ultragenyx Pharmaceutical	05/10/2016	10-Q	10-Q filing on 05/10/2016	View Form
RARE Ultragenyx Pharmaceutical	02/26/2016	10-K	10-K filing on 02/26/2016	View Form
RARE Ultragenyx Pharmaceutical	11/10/2015	10-Q	10-Q filing on 11/10/2015	View Form
RARE Ultragenyx Pharmaceutical	08/14/2015	10-Q	10-Q filing on 08/14/2015	View Form
RARE Ultragenyx Pharmaceutical	05/12/2015	10-Q	10-Q filing on 05/12/2015	View Form

Related Companies

Get RARE Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

RARE

Sector

P/E ratio

--

24.20x

PEG ratio

--

0.00x

P/B ratio

13.76x

1.67x

Price / LTM sales

6.14x

1.70x

Growth Metrics

RARE

Sector

Revenue growth

29.43%

6.5%

Earnings growth

--

6.56%

Revenue (5-year growth)

40.12%

8.92%

Earnings forecast

-$1.27

-$0.19

Profitability

RARE

Sector

Profitability FY 2024

$483.5M

$56.3M

Return on invested capital

-194.36%

-14.46%

Return on assets

-38.16%

-11.82%

Return on equity

-194.36%

-16.77%

Earnings Date

Last Earnings Date

Feb

13

Next Earnings Date

May

2

Estimated Next Earnings Date

May

15

Balance Sheet

RARE

Sector

Total cash

$610M

$41.7M

Short term investments

$436.3M

$38.7M

Total assets

$1.5B

$125.9M

Long term debt

--

$9.9M

Stock Ideas

Buy

56

Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy or Sell?

Buy

53

Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy or Sell?

Sell

46

Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Buy or Sell?

Alerts

Buy

74

SLNO alert for Mar 27

Soleno Therapeutics [SLNO] is up 37.64% over the past day.

Buy or Sell?

Buy

68

WOR alert for Mar 27

Worthington Enterprises [WOR] is up 0.16% over the past day.

Buy or Sell?

Sell

14

VRT alert for Mar 27

Vertiv Holdings [VRT] is down 6.57% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Ultragenyx Pharmaceutical SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get RARE Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did HealthEquity Stock Fall So Much?

Why Did Super Micro Stock Fall So Much?

Is Diamondback Energy a Good Stock to Buy?

Stock Ideas

Is AAPL Stock a Buy?

Is MSFT Stock a Buy?

Is NVDA Stock a Buy?

Alerts

SLNO alert for Mar 27

WOR alert for Mar 27

VRT alert for Mar 27

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS